Zykadia (ceritinib)

pCPA File Number: 20820
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Small Cell Lung Cancer (metastatic)
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
pCODR 10062
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: